1. Introduction
Click reactions have garnered significant interest in the broader areas of materials science and bioconjugation owing to their fast reaction kinetics, high regioselectivity, and efficient reaction yields, all under mild conditions.1–4 Many click chemistries have been applied to the production of materials, including the traditional azide-alkyne, Diels-Alder, Michael addition, thiol–ene, and oxime reactions.3, 5 In particular, click reactions that do not require a catalyst or initiator and are free of byproducts, such as the reaction of maleimides and thiols, are useful for biological applications owing to their cytocompatibility in the presence of proteins, cells, or tissues.6, 7 Utilizing these reactions, injectable hydrogels can be easily created as delivery vehicles for therapeutics, particles, or cells.8–10 In this application, temporal changes in material properties caused by degradation allow the controlled release of therapeutics, the elaboration of secreted matrix by encapsulated or infiltrating cells, or the spreading, migration, and release of encapsulated cells.11–13
Cleavage of the click linkages provides an attractive and relatively cost-effective approach to incorporate degradability without the use of more complex components, such as degradable peptides or proteins. Recent studies have demonstrated the degradability of click crosslinks under mechanical14, 15 and thermal16, 17 stresses; however, such reaction conditions can limit the translation of these approaches into clinical applications owing to the limited cytocompatibility of their associated stimuli. Overcoming this limitation, Baldwin and Kiick have recently introduced thiol-maleimide click reactions in solution and within PEG-heparin hydrogels that are sensitive to reducing microenvironments found in vivo.10, 18 Opportunities to exploit these strategies for controlled delivery of encapsulated cargo molecules, however, have not yet been demonstrated.
Despite recent technological advances, the delivery of therapeutic proteins (e.g., Trastuzumab, Bevacizumab, Rituximab) and small molecule drugs (e.g., Fluorouracil, Paclitaxel) remains a major challenge in the treatment of many diseases, including cancer.19 In approaches for cancer treatment, delivery to the site of a tumor is critical for therapeutic success and minimization of side effects.20 Injectable hydrogel-based drug carriers offer advantages for these applications, enabling the efficient encapsulation of cargo molecules while maintaining bioactivity for localized delivery at a preprogrammed rate or responsive manner.21–24 Depending on the cargo molecule of interest, the rate of release can be controlled by diffusion, degradation, affinity, or a combination of these mechanisms through hydrogel design. Degradation-mediated release is a versatile approach for the temporally controlled delivery of numerous payloads, from hydrophilic proteins to small molecules caged within nanoparticles, without chemical modification of the therapeutic, which can affect drug efficacy and clinical translation.25–27 Several strategies have been employed to incorporate degradability within the hydrogel by inclusion of labile crosslinks, including esters,28, 29 photolabile groups,30–32, and enzyme-sensitive linkers.25, 33 As will be elaborated below, linkers that are sensitive to reductants are attractive and simple for controlled release in cancerous tissues, which have elevated levels of sulfur-containing compounds.34
Accordingly, reduction-sensitive disulfide linkages have been widely used for intracellular delivery of DNA, siRNA, proteins, and therapeutic drugs.35–39 These strategies rely on rapid destabilization of the drug carrier due to reduction of disulfide bonds in the presence of glutathione (GSH) tripeptides, one of the major sulfur-containing compounds found at elevated levels within cancerous tissues and cells.40, 41 Since the intracellular concentration of GSH (ca. 0.5 mM to 10 mM) is 100 to 1000 times higher than the extracellular concentration (ca. 0.001 mM to 0.02 mM), efficient intracellular delivery of cargo molecules has been achieved using disulfide chemistry.42, 43 However, the rapid rate of degradation of disulfide linkages provides limited control over material degradation and cargo release, and GSH-sensitive linkers that permit controlled extracellular delivery over days to weeks thus have been less explored. In addition, since the concentration of GSH is higher in carcinoma tissues than in healthy tissues due to abnormal proliferative activities of cancer cells,40, 41, 44 reducing sensitive chemistries incorporated within drug delivery carriers offer great potential for localized cancer treatment. To address this need and opportunity, we present reducing microenvironment-sensitive hydrogels that undergo tunable degradation on the order of days to weeks for controlled protein delivery, demonstrating the broad utility of the click bond cleavage and thiol exchange reaction as a general strategy not only to control degradation but also to control the release of cargo molecules locally from a bioinert delivery vehicle.
Specifically, we describe the development of multimode, degradable poly(ethylene glycol) (PEG) hydrogels using Michael-type addition and exchange reactions by incorporation of select thioether succinimide crosslinks. These hydrogels are composed of multifunctional PEG crosslinked using thiol-maleimide click chemistry and can undergo degradation by two mechanisms: i) cleavage of click linkages and thiol exchange reactions in the presence of GSH and ii) ester hydrolysis. To achieve this, multiarm PEG macromers were functionalized with different mercaptoacids and reacted with maleimide-functionalized PEG, creating hydrogels that degrade by either hydrolytic or hydrolytic and thiol-exchange mechanisms. Hydrogel degradation was monitored in physiologically-relevant GSH microenvironments via oscillatory rheometry and volumetric swelling measurements to assess the degradation kinetics. The ability to incorporate and selectively release a cargo molecule was investigated by monitoring, via fluorescence spectroscopy, the release of bovine serum albumin (BSA) as a model protein. The ability to precisely control hydrogel degradation and thus the release profile of cargo molecules using cleavage of click linkages offers exciting avenues for designing biomaterials for drug delivery and tissue engineering applications.
2. Methods and Materials
2.1 Materials
4-arm hydroxyl-functionalized poly(ethylene glycol) (PEG-4-OH, 10000 g mol−1), 4-arm thiol-functionalized PEG (PEG-4-SH, 10000 g mol−1), and linear maleimide-functionalized PEG (PEG-2-MI, 5000 g mol−1) were purchased from JenKem Technology USA Inc. (Allen, TX). 3-Mercaptopropionic acid (MP), 4-mercaptophenylacetic acid (MPA), p-toluenesulfonic acid monohydrate (PTSA), triethylamine (TEA), dithiothreitol (DTT), and glutathione (GSH) were purchased from Sigma-Aldrich (St. Louis, MO). Trifluoroacetic acid (TFA) and all solvents were obtained from Fisher Scientific (Pittsburgh, PA). Bovine serum albumin labeled with Alexa Fluor 488 (BSA-488) was purchased from Life Technologies (Grand Island, NY). All commercially available reagents were used as received without further purification unless otherwise noted.
2.2 Synthesis of mercaptoacid-based PEG-thiols
PEG was modified with MP or MPA functional groups based on modified versions of previously published protocols.8, 10 Briefly, PEG-4-OH (0.1 mmol), mercaptoacid (4 mmol), PTSA (0.04 mmol), and toluene (20 mL) were added to an oven-dried round-bottom flask equipped with a reflux condenser. The reaction setup was purged with nitrogen under room temperature. The reaction (Scheme 1) was heated to reflux (110 °C) and stirred for 48 hours, and generated water was collected by using a Dean-Stark trap. Upon completion, the reaction was cooled to room temperature, and the functionalized PEG precipitated three times in ethyl ether. The product was recovered by vacuum filtration and rinsed with 2-propanol followed by hexane. The dried polymer product (1 equiv) was reduced in toluene using DTT (1 equiv) and TEA (1 equiv) for 5 hours, under inert atmosphere. The finished reaction was acidified with TFA (1.1 equiv), and the polymer was again precipitated in ethyl ether and recovered by filtration. Subsequently, the polymer was dissolved in methanol, and the mixture was filtered through a 0.22 µm filter followed by precipitation in 2-propanol and vacuum filtration. The solid product was rinsed with copious amounts of 2-propanol and hexane. The final dried polymer was obtained by removal of residual solvents under reduced pressure. The degree of thiol functionalization of the polymer was characterized via 1H NMR spectroscopy, using a Bruker AV 400 NMR spectrometer (Bruker Daltonics, Billerica, MA) with CDCl3 as the solvent and TMS as the reference.
PEG-4-MP
The general procedure for synthesis of PEG-thiol was followed using MP as the mercaptoacid to yield PEG-4-MP. The final polymer was obtained as a white solid (0.6 g, 74% yield). The functionality was estimated to be 92% based on integration of the proton neighboring the ester linkage relative to the PEG backbone protons. (Fig. S1 B).
1H NMR (400 MHz, CDCl3) δ: 4.28 (8H, t), 3.90–3.35 (900H, bs), 2.82–2.62 (16H, m), 1.68 (4H, t).
PEG-4-MPA
The general procedure for synthesis of PEG-thiol was followed using MPA as the mercaptoacid to yield PEG-4-MPA. The final polymer was obtained as a white solid (0.54 g, 66% yield). The functionality was estimated to be 90% based on integration of the proton neighboring the ester linkage relative to the PEG backbone protons (Fig. S1 C).
1H NMR (400 MHz, CDCl3) δ: 7.24–7.08(16H, m), 4.24 (8H, t), 3.90–3.35 (900H, bs), 3.42–3.39 (4H, s).
2.3 Gelation time and rheology characterization
Hydrogel precursor solutions were prepared by dissolution of thiol- and maleimide-functionalized PEG (5% w/w) in citric acid buffer (pH 5) and phosphate-buffered saline (pH 7.4), respectively. Slightly acidic conditions allowed tuning of the gelation time (i.e., increased gelation time) due to the reduced nucleophilicity of thiolate species under acidic conditions;10, 45 these polymerization conditions previously have been shown to be effective for use in cell/protein studies in vitro.46 Gelation time was studied qualitatively using the tube inversion method. Briefly, the hydrogel precursor solutions were mixed (100 µL) and immediately pipetted into a glass vial. In five-second intervals, vials were inverted to observe if the solution flowed. The timepoint at which the solution did not flow was recorded as the gelation time.
For rheological studies, the hydrogels were formed directly on the rheometer (AR-G2, TA instruments, USA) by mixing the precursor solutions (1:1 maleimide:thiol molar ratio resulting in 5 % w/w hydrogels), immediately pipetting onto a Peltier plate at 25 °C, and commencing measurements (120 µm gap). Gelation at room temperature ensured that the gelation time was sufficiently slow to allow good mixing of precursor solutions on the Peltier plate prior to gelation. This also allowed the gels to form homogeneously so that all gels had similar moduli prior to protein release experiments. The gelation time and final shear modulus of the hydrogel were determined using rheometry experiments. Frequency sweeps were performed to determine the linear viscoelastic regime (0.01 to 10 % strain at 6 rad/s). Using a 20-mm diameter parallel plate geometry, time-sweep measurements were obtained within the linear viscoelastic regime (1 % constant strain mode at a frequency of 6 rad/s) at 25 °C.
2.4 Hydrogel degradation characterization
For hydrogel degradation studies, polymer precursor solutions (5% w/w) were mixed in a 1:1 maleimide:thiol molar ratio and pipetted into a cylindrical mold (diameter = 4.6 mm, thickness = 1.8 mm). The solutions were allowed to gel for two hours at room temperature to ensure maximum possible crosslink density was achieved for all samples. The rheological data showed that once the gels have been formed (i.e., stable storage moduli is achieved at 30 min), the moduli remain consistent through 2 hours. The resulting hydrogels were washed with PBS and incubated, at room temperature, in 5 mL of PBS buffer (pH 7.4) containing GSH (0 mM, 0.01 mM or 10 mM) over the experimental time period. The pH of the buffer after GSH addition was adjusted to a pH of 7 by addition of 0.1 M sodium hydroxide. Degradation was monitored by measuring volumetric swelling and shear modulus. For the shear modulus measurements, time sweeps were performed within the linear viscoelastic regime for each sample (2 rad/s, 2% strain, and 0.25 N normal force in order to prevent hydrogel slip).
2.5 Volumetric swelling and mesh size calculations
Hydrogel discs (diameter = 4.6 mm, thickness = 1.8 mm) were placed in PBS buffer with 0 mM, 0.01 mM, or 10 mM GSH at room temperature and gently rocked. Samples were removed at respective time points, and the diameters of hydrogels were measured using a Vernier caliper, whereas the height was determined using the rheometer gap values. Volume of the hydrogel at each time points was determined based on measured diameter and height and assuming cylindrical geometry. The % volumetric swelling at each time point was calculated by normalizing to the volume of the gel immediately after formation (day 0 before equilibrating with PBS).
2.6 Protein release
For protein release experiments, polymer precursor solutions (5% w/w) were mixed in a 1:1 maleimide:thiol molar ratio along with BSA-488 (loading concentration 1.2 mg/ml) and added to a cylindrical mold (diameter = 4.6 mm, thickness = 1.8mm). The solutions were allowed to gel for two hours at room temperature. Hydrogel discs were immediately washed with PBS thrice to remove any non-encapsulated BSA-488 and then gently rocked at room temperature in 5 mL of PBS buffer with GSH (10 mM). The amount of BSA-488 present in the hydrogel was calculated by subtracting the amount of BSA-488 released during wash steps from the amount of BSA-488 that was initially loaded into the gel. At each time point, a 100-µL aliquot of the sink solution was removed for protein release measurements and replaced by 100 µL of fresh GSH in PBS. The released BSA-488 was quantified by fluorescence measurements using a microplate reader (Synergy H4, BioTek Inc., Winooski, VT) taking into account the cumulative sample dilution due to removal and addition of fresh GSH in PBS at each time point measurement (see Supporting Information). To estimate the concentration of released BSA-488, a calibration curve for the fluorescence of BSA-488 as a function of its concentration was acquired. The release of the BSA was monitored via SDS-PAGE analysis of the solutions removed at each timepoint; 7 µL of sink solution containing released protein was loaded onto a standard sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for analysis. The concentration of protein in each band was quantified with densitometry analysis using the gel analysis function in ImageJ (version 1.46).
2.7 Statistical analysis
Results are expressed as mean ± standard error of mean (SEM) unless otherwise specified. Monomer synthesis reactions were performed in duplicate. Hydrogel formation experiments were performed in triplicate. Degradation and protein release studies were performed in duplicate with 3 hydrogels per condition at each experimental time point. Statistical comparisons were based on analysis of variance (ANOVA) and p < 0.05 was considered statistically significant.
3. Results and Discussion
3.1 Hydrogel compositions for control of degradation
Many natural and synthetic polymers have been used for hydrogel formation, with polymer selection partly dictated by the application of interest.5 PEG-based hydrogels are well suited for drug delivery applications owing to their biocompatibility, lack of protein binding sites, and the ease of engineering their properties.47 The facile functionalization of the hydroxyl end groups of PEG allows the incorporation of different chemical functionalities for hydrogel formation in the presence of proteins and cells and for controlled degradation. Exploiting these advantages, PEG-OH was functionalized with alkyl (MP) and aryl (MPA) based mercaptoacids utilizing established protocols.8, 10 These thiol end groups act as nucleophiles and react rapidly with maleimide functional groups to form crosslinks by a Michael-type addition reaction. Michael-type addition reactions are highly efficient and versatile reactions that occur under physiological conditions without byproducts and have been used to crosslink cytocompatible hydrogels.48–50 Here, the composition of the hydrogel was varied to enable microenvironment-controlled degradation and protein release (Fig. 1). PEG-4SH-based hydrogels (Control), which contain water stable ether bonds, served as a non-degradable control owing to lack of any degradable functional groups. Owing to the presence of ester linkages, MP-based hydrogels (one degradable group, D1E) undergo ester hydrolysis, whereas the MPA-based hydrogels (two degradable groups, D2ER) undergo ester hydrolysis and click bond cleavage and thiol exchange reactions.
3.2 Consistent hydrogel formation
Dynamic time sweep experiments were conducted to study hydrogel gelation kinetics and final hydrogel moduli. Data were acquired within the linear viscoelastic regime. After vortexing the precursor solutions, the storage and loss moduli were recorded as a function of time. Representative results for the D2ER hydrogel formation are shown in Fig. 2A. The crossover point (i.e., G'=G"), which is an indirect measurement of the gel point, was not observed due to the rapid onset of gelation before the first data point was acquired; the gelation time thus was semi-qualitatively determined by the tube inversion method.51 Faster gelation was observed for D2ER (~20 sec) compared to D1E (~35 sec) and Control (~40 sec) hydrogels; this rapid gelation is consistent with the reported kinetics of thiol-maleimide reactions.52 The time difference for gelation between D2ER, D1E, and Control can be attributed to the thiol reactivity (D1E and Control, alkylthiols pKa = 10.2; D2ER, arylthiols pKa = 6.6).53, 54 The difference in thiol reactivity of Control, D1, and D2ER essentially arises from the mesomeric effect provided by the aromatic ring in the case of D2ER, making it more nucleophilic than Control and D1E.
Presence of aromatic ring in D2ER results in higher nucleophilicity due to mesomeric effect, which dictates the thiol reactivity. With increasing time, the storage modulus (G') increases rapidly without a significant increase in loss modulus (G"). These data highlight the elastic nature of the network. Time to achieve final storage moduli varied depending upon the identity of thiol groups, which again can be attributed to the thiol reactivity (D2ER: ~15 minutes; D1E: ~30 min; and Control: ~34 min). Although the experiments were performed at the room temperature (25 °C), the gelation time and time to achieve the final storage moduli can be further decreased by forming hydrogels at elevated temperatures.
Material modulus is directly correlated with the crosslink density as per the theory of rubber elasticity.55 The final storage moduli, which is defined as the value of G' after reaching plateau, for Control, D1E, and D2ER hydrogels were examined to compare the consistency in crosslink density between the different compositions (Fig. 2B). The final post-gelation, equilibrium-swollen G' were recorded after complete gelation for Control, D1E, and D2ER. As indicated in the figure, the post gelation equilibrium G' was ~2.3 kPa for all three compositions. There were no statistically significant differences between the final plateau moduli of the various gels (one-way ANOVA, p = 0.88), indicating that the use of different thiols did not affect the final crosslink density substantially. Side reactions such as disulfide formation and maleimide ring hydrolysis alter the reactivity of the thiol and maleimide groups and thus could affect the number of functional groups available for hydrogel formation (Scheme S1), potentially decreasing the final moduli for a particular composition. The lack of a statistically significant difference between the final equilibrium G' values thus also suggests that there were no significant differences in the extent of these side reactions for the various hydrogel compositions. These results suggest that differences in gelation for Control, D1E, and D2ER did not significantly contribute to network defects due to strict 1:1 stoichiometry and relative rate of Michael-type addition as compared to other defect forming side reactions. Further, the molecular weight of the PEG chains for the gel compositions investigated here was selected to minimize any looping, unreacted functionalities, and other related network defects based on studies of related PEG hydrogels in the literature.45 The similarity of the initial crosslink densities between the Control, D1E, and D2ER hydrogels allow the study of the degradation kinetics by direct monitoring of changes in G' as a function of time.
3.3. Degradation in a reducing microenvironment
In order to evaluate the most rapid hydrogel degradation that might be observed in physiologically relevant reducing microenvironments, as well as to evaluate the associated degradation mechanism, the higher GSH of 10 mM first was examined. Potential degradation mechanisms for each hydrogel composition are described in Fig. 3. Thioether succinimide linkages formed using arylthiols (D2ER hydrogels) can undergo thiol exchange in the presence of exogenous thiols (a GSH-rich microenvironment) in contrast to alkylthiols (Control and D1E), which are stable within the experimental time frame (stable at t < 6 days).18 The presence of ester linkages in the D1E and D2ER hydrogels allows degradation by ester hydrolysis over longer time scales (stable at t > 1 month to 2 years depending upon neighboring groups).56 A potential hindrance to degradation by the thiol exchange mechanism is possible hydrolysis of the maleimide ring, which leads to ring opening and the formation of an irreversible crosslink. However, the rate of maleimide ring hydrolysis is significantly slower (by one order of magnitude) than the competing click cleavage and thiol exchange reaction (k = 3.7 × 10−2 h−1 for click cleavage and thiol exchange, k = 3.3 × 10−3 h−1 for maleimide ring hydrolysis).18 Consequently, we assume that changes in G' for D2ER hydrogels are dominated by mainly thiol-exchange reactions in reducing microenvironments and by ester hydrolysis in non-reducing microenvironments.
Oscillatory rheometry and volumetric swelling measurements were used to study the degradation of the hydrogels (defined here as the scission of network crosslinks) under thiol-rich reducing conditions. Degradation kinetics were assessed by measuring the storage moduli of hydrogel discs that were suspended in solutions containing 10 mM GSH (Fig. 4A). The storage moduli at each time point were normalized to the initial modulus for that gel composition directly after formation (day 0 before equilibrating with PBS), where the initial gel has a normalized modulus of 100%. As illustrated in the figure, the Control and D1E samples exhibited an initial decrease in G' to approximately 80% of the normalized value within 24 hours, but did not exhibit any further rapid decrease in moduli after this point. The initial decrease can be attributed to the equilibrium swelling that occurs after hydrogel formation. No significant change was observed in G' post-equilibrium swelling for Control hydrogels, which was expected since no degradable functional groups are present within these hydrogels. A slight decrease in modulus over time was observed for D1E hydrogels, which can be attributed to ester hydrolysis (calculated first-order rate constant, k = 3.33 × 10−5 min−1). This rate constant compares well with the typical ester linkage hydrolysis rate constant in hydrophilic polymer networks (1.33 × 10−5 to 7.33 × 10−6 min−1) corresponding to half lives of 6 to 32 days.57 The degradation rate constant for D1E was found to be statistically different from the Control (two-tailed P value = 0.005), highlighting the role of ester linkages in the degradation of D1E (Fig. S3 and S4). In contrast, a rapid decrease in G' was observed for D2ER hydrogels, and the reverse gel point, defined as complete hydrogel dissolution, was observed after approximately 4 days (at 5700 minutes). The rapid decrease in G' indicates a substantial decrease in crosslink density and can be attributed to the reversibility of the thiol-maleimide reaction and the consequent thiol exchange reactions that occur in the presence of GSH. As the rates of ester hydrolysis and maleimide ring hydrolysis are slow, the rapid rate of degradation of D2ER highlights the role of click bond cleavage and thiol exchange reaction as leading cause of hydrogel degradation.
Temporal changes in the volumetric swelling also were examined for the Control, D1E, and D2ER hydrogels that were suspended in 10 mM GSH (Fig. 4B). All three hydrogel compositions showed an initial increase in the swelling as the hydrogels achieved equilibrium swelling. The Control and D1E hydrogels remained stable after this initial swelling event (t > ~24 hours), whereas the volumetric swelling for D2ER hydrogels continued increasing until complete degradation (gel dissolution) occurred at 5700 minutes. The continuous increase in the swelling before complete degradation for D2ER is consistent with a bulk degradation mechanism, as well as with the rheometric measurements where the increases in swelling are commensurate with observed decreases in modulus. Overall, these results indicate that well-defined hydrogels can be designed to degrade in a reducing microenvironment with selection of arylthiol-based thioether succinimide linkages. Such a system could prove useful in the design of hydrogels for controlled and local delivery of anti-cancer drugs.
3.4 Influence of GSH concentration on hydrogel degradation
To reject the possibility that the degradation of D2ER hydrogels under high [GSH] conditions was substantially affected by ester hydrolysis, the mechanical properties of D2ER hydrogels were monitored in solutions lacking GSH (0 mM GSH). In addition, since thiol exchange reactions are dependent on GSH concentration, we investigated an additional condition (0.01 mM GSH, D2ER hydrogel), which mimics the extracellular GSH concentration. The storage moduli (G') of hydrogels were measured at predetermined time points. The Control hydrogel exhibited an initial decrease in G' over the first 24 hours, after which G' did not change, irrespective of GSH concentration (0 and 10 mM, Fig. S3). As discussed in Section 3.3, the initial changes in G' can be attributed to equilibrium swelling. The constant moduli observed for timepoints after 24 hours indicate that the polymeric crosslinks are stable within the experimental timeframe and do not undergo any significant degradation. For D1E hydrogels, the storage moduli initially decreased, which again can be attributed to equilibrium swelling (Fig. S4). However, for the D1E hydrogel, the decrease in storage moduli continued past 24 hours, which would be consistent with degradation via ester hydrolysis as discussed above.
As shown in Fig. 5, the storage moduli varied as a function of GSH concentration for D2ER hydrogels. For the 0 mM GSH condition, G' initially decreased during the first 24 hours, owing to equilibrium swelling, followed by a slow decrease in G' to 81% of its initial normalized value. The decrease after 24 h can be attributed to ester hydrolysis (k = 1.35 × 10−5 min−1, t1/2 = 35 days). For 0.01 mM GSH, G' decreases rapidly and complete gel degradation was observed at approximately 8 days (t ~200 h), indicating that the degradation mechanism in the presence of glutathione is dominated by the reversibility of the thiol-maleimide reaction and the resulting thiol exchange that is possible in the presence of GSH. Further, in comparison with solutions containing 10 mM GSH, these data highlight the dependence of the rate of D2ER hydrogel degradation on GSH concentration. At lower GSH concentration, the free thiol groups (~14 µM) generated due to the click bond cleavage compete with the free GSH thiols (~10 µM), since the concentration is comparable. In this case, the GSH concentration is a limiting factor, and the rate of degradation is significantly slower for 0.01 mM compared to the 10 mM GSH condition, in which GSH is present in a large excess. Overall, these results indicate that the D2ER hydrogels can undergo ester hydrolysis, but the rate of ester hydrolysis is very slow (under 0 mM GSH k ~ 10−5 min−1). As rapid degradation of D2ER hydrogels is observed under reducing conditions (10 mM GSH k ~ 10−3 min−1), the data clearly indicate that the click bond cleavage and thiol exchange reaction is the primary mechanism for gel degradation. Further, to verify that D2ER hydrogels can undergo complete degradation via ester hydrolysis, D2ER hydrogels were subjected to basic conditions to accelerate ester bond hydrolysis (0.1 M sodium carbonate buffer, pH 11.5) and exhibited complete degradation within 24 hours in the absence of a reducing microenvironment, confirming the dual degradability of the hydrogels.
To further investigate the mode of degradation, temporal changes in the volumetric swelling were monitored for D2ER hydrogels suspended in various reducing microenvironments (Fig. 5B). During the first 24 hours, the volumetric swelling increases for all three conditions, which can be attributed to initial hydrogel equilibrium swelling. After 24 hours, the volumetric swelling continuously increases for the 0.01 mM and 10 mM condition over the course of degradation, which is consistent with rheometric measurements. A bulk degradation mechanism is indicated by this continuous increase in the swelling as a function of time.25, 58
3.5 Degradation Kinetics
Regression analysis was conducted to obtain further insight into the degradation mechanism of D2ER hydrogels and the kinetics of associated degradation reactions (Fig. 6). When exposed to 0 mM GSH, the decrease in storage moduli can be attributed to ester hydrolysis. Owing to the highly swollen nature of the hydrogels, and since the buffer is present in large excess, the water concentration during the degradation time period can be assumed to be relatively constant. Hence, the reaction kinetics was observed to be pseudo-first order with a rate constant 1.87 × 10−5 ± 5.83 × 10−6 min−1. The differences in the rate of ester hydrolysis calculated for the D2ER (here) and D1E hydrogels (above) can be attributed to local hydrophobic domains associated with aryl thiols in the D2ER gels, consistent with a previously reported study by Schoenmakers et al. in which the rate of ester hydrolysis varied with local hydrophobicity.59 When D2ER gels were exposed to 0.01 mM GSH, a rapid decrease in G' was observed, consistent with the occurrence of both thiol exchange reactions and ester hydrolysis. Because the theoretical concentration of thiol groups from PEG is comparable to that of the thiol groups from GSH (see above), the rate of hydrogel degradation is dependent both on the concentration of degradable functional groups (which correlate with the crosslink density with 2 degradable groups per crosslink) and the concentration of GSH. Consistent with this, the hydrogel degradation kinetics were observed to be second order, with a rate constant 5.03 × 10−6 ± 0.16 × 10−6 mM−1 min−1. With a higher concentration of GSH, the D2ER hydrogel rapidly degrades. At 10 mM GSH, the GSH is present in large excess (~3 orders of magnitude as compared to thiols present in the hydrogel), and thus the concentration of GSH can be assumed to be constant during the experimental time frame. Thus, the rate of degradation is dependent on only the crosslink density, and first order degradation kinetics regression analysis yields a rate constant of 1.75 × 10−3 ± 0.26 × 10−3 min−1. The degradation rate constants for the Control, D1E, and D2ER hydrogels are been summarized in Table S1.
3.6 Controlled release of a model protein
The ability to tune the rate of degradation by varying crosslink chemistry offers opportunities to utilize these hydrogels for the controlled release of therapeutics in response to the reducing microenvironment or at a preprogrammed rate by ester hydrolysis. To study the applicability of these hydrogels for controlled release applications, a fluorescently-tagged model protein, bovine serum albumin (BSA-488), was encapsulated during hydrogel formation. BSA-488 was chosen as a model protein for release studies since the hydrodynamic diameter (~ 7.2 nm)60 is comparable to the estimated hydrogel mesh size (~ 9 nm). The size of the BSA and mesh size calculated for the hydrogels suggest that these materials would be useful for tailored release by hydrogel degradation, upon which the mesh size becomes large enough to facilitate protein release. Similarly, bioactive proteins (e.g., growth factors), therapeutic-laden nanoparticles, or even cells could be released by this mechanism.
The release of BSA-488 was monitored by measuring fluorescence as a function of time. The percent cumulative release was plotted as a function of time for all three compositions (Fig. 7A). Approximately 40 % of BSA-488 was initially released from all hydrogel compositions (Control, D1E, and D2ER hydrogels). This release may be attributed to the increase in mesh size associated with initial equilibrium swelling. The effective diffusion coefficient (De) was calculated using a modified form of Fick’s law61, 62 and the value was found to be ~ 1.56 × 10−8 cm2 sec−1 (see Supporting Information). This value of De is in agreement with previously reported De values for BSA release from PEG hydrogels.63 D2ER hydrogels, which undergo rapid degradation in reducing microenvironments owing to thiol exchange reactions, exhibited degradation-dependent release, with ~95 % of the cargo released after approximately 4 days, commensurate with when complete hydrogel degradation was observed. This result suggests that the degradation reaction broadly modulates the release of the cargo molecule. Here, the De was found to be 5.70 × 10−8 cm2 sec−1. The difference between the effective diffusion coefficients for the hydrogel compositions correlates with the degradation profile of these hydrogels.
SDS PAGE was employed to assess the molecular mass of the released BSA as an indirect measure of its stability during encapsulation and release from the various hydrogel compositions (Fig. 7B). Lanes 2 and 3 in the figure, which served as controls, were loaded with BSA-488 in PBS buffer containing 10 mM GSH prepared at two different time points (i.e., just before electrophoresis and before starting the release experiment for BSA-488, respectively). Lane 4, 5, and 6 were loaded with sink solution containing released BSA-488 from the Control, D1E, and D2ER hydrogels, respectively. No major differences were observed between the band locations. These results suggest that there were no substantial changes in the overall hydrodynamic volume or molecular weight of the protein during encapsulation and release. Densitometry analysis was carried out using NIH Image J software. The band intensity from lane 3 was normalized to 100%, and compared with the band intensity of released BSA from the Control (~33%), D1E (~36%), and D2ER (~90%) hydrogels. The results correlated well with the protein release data obtained using fluorescence measurements. Taken together, these results suggest the utility of GSH-responsive hydrogels as a drug carrier for controlled cargo release applications. However, for applications where rapid release (~1 to 3 hours) of cargo is desired in response to reducing microenvironment, disulfide linkages still may be more appropriate.
Few studies have reported the use of dually degradable hydrogels for tissue engineering and cell encapsulation applications,28, 64 and the use of dually degradable hydrogels for controlled release applications has been limited. Recently, Wang and co-workers investigated use of dually degradable hydrogels for protein release studies by incorporating an enzymatically degradable hyaluronic acid based backbone and chemically cleavable disulfide linkages.65 Depending on concentration of hyaluronidase and GSH, the hydrogel exhibited significant degradation within the first ~1.5 to 5 hours, and complete release of a cargo molecule (stromal cell-derived factor 1α, 100 ng) was achieved within approximately 8 hours. The click cleavage and subsequent thiol exchange system presented here undergoes degradation on a significantly longer timescale (~ 4 days) offering advantages for controlled drug delivery, where wider control over degradation can help transition to clinical applications. In addition, incorporation of ester linkages affords long term clearance of these hydrogels from in vivo microenvironments due to ester hydrolysis and subsequent degradation.
4. Conclusions
In this work, we report dually degradable PEG hydrogels in which degradation can be tailored, without affecting hydrogel formation, by the Michael-type addition of select functional groups that yield crosslinks with tunable, and previously unexplored, degradation mechanisms. This facile approach enables hydrogel formation by broadly useful thiol-maleimide click chemistry employing arylthiols, while eliminating the need for the additional incorporation of more complex and potentially costly labile chemistries within the crosslinker to facilitate degradation, such as enzyme-labile peptides. The rate of hydrogel degradation was found to be dependent upon the chemistry of linker, the number of degradable crosslinks, and the concentration of the reducing microenvironment. The release of a model protein from these hydrogels demonstrates the potential of these matrices and approaches for controlled release applications in thiol-rich reducing microenvironments. Control of degradation rates permitted a 2.5-fold difference in protein release for the dually degradable (D2ER) as compared to the non-degradable (Control) or single-mode degradable (D1E) hydrogels. In principle, this strategy could easily be employed for controlled release over different time frames using combinations of these thiol functional groups within a single hydrogel or utilized in conjunction with more elaborate degradable chemistries when desired for more complex degradation and release profiles. The degradation of hydrogels by cleavage of click linkages presents considerable opportunities in the design of materials for controlled drug delivery and soft tissue engineering applications.
Supplementary Material
Acknowledgements
Research reported in this publication was supported by Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103541 and the University of Delaware Research Foundation. The authors thank Dr. Wilfred Chen for use of the plate reader. The authors thank Rachel Kennel for technical help with precursor solution and hydrogel preparation. Additionally, the authors would like to thank Matthew Rehmann, Megan Smithmyer, Lisa Sawicki, and Kelsi Skeens for feedback on earlier versions of this manuscript.
Contributor Information
April M. Kloxin, Email: akloxin@udel.edu.
Kristi L. Kiick, Email: kiick@udel.edu.
References
- 1.Moses JE, Moorhouse AD. Chem Soc Rev. 2007;36:1249–1262. doi: 10.1039/b613014n. [DOI] [PubMed] [Google Scholar]
- 2.Manetsch R, Krasinski A, Radic Z, Raushel J, Taylor P, Sharpless KB, Kolb HC. J Am Chem Soc. 2004;126:12809–12818. doi: 10.1021/ja046382g. [DOI] [PubMed] [Google Scholar]
- 3.Nimmo CM, Shoichet MS. Bioconjug Chem. 2011;22:2199–2209. doi: 10.1021/bc200281k. [DOI] [PubMed] [Google Scholar]
- 4.Kolb HC, Finn MG, Sharpless KB. Angew Chem Int Ed Engl. 2001;40:2004–2021. doi: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
- 5.Kharkar PM, Kiick KL, Kloxin AM. Chem Soc Rev. 2013;42:7335–7372. doi: 10.1039/c3cs60040h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pounder RJ, Stanford MJ, Brooks P, Richards SP, Dove AP. Chem Commun. 2008:5158–5160. doi: 10.1039/b809167f. [DOI] [PubMed] [Google Scholar]
- 7.Azagarsamy MA, Anseth KS. ACS Macro Lett. 2013;2:5–9. doi: 10.1021/mz300585q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nie T, Baldwin A, Yamaguchi N, Kiick KL. J Control Release. 2007;122:287–296. doi: 10.1016/j.jconrel.2007.04.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wang H, Han A, Cai Y, Xie Y, Zhou H, Long J, Yang Z. Chem Commun. 2013;49:7448–7450. doi: 10.1039/c3cc43711f. [DOI] [PubMed] [Google Scholar]
- 10.Baldwin AD, Kiick KL. Polym Chem. 2013;4:133–143. doi: 10.1039/C2PY20576A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tibbitt MW, Han BW, Kloxin AM, Anseth KS. J Biomed Mater Res A. 2012;100:1647–1654. doi: 10.1002/jbm.a.34107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Adelow C, Segura T, Hubbell JA, Frey P. Biomaterials. 2008;29:314–326. doi: 10.1016/j.biomaterials.2007.09.036. [DOI] [PubMed] [Google Scholar]
- 13.Brandl FP, Seitz AK, Tessmar JK, Blunk T, Gopferich AM. Biomaterials. 2010;31:3957–3966. doi: 10.1016/j.biomaterials.2010.01.128. [DOI] [PubMed] [Google Scholar]
- 14.Brantley JN, Wiggins KM, Bielawski CW. Science. 2011;333:1606–1609. doi: 10.1126/science.1207934. [DOI] [PubMed] [Google Scholar]
- 15.Wiggins KM, Brantley JN, Bielawski CW. Acs Macro Letters. 2012;1:623–626. doi: 10.1021/mz300167y. [DOI] [PubMed] [Google Scholar]
- 16.Dispinar T, Sanyal R, Sanyal A. J Polym Sci A Polym Chem. 2007;45:4545–4551. [Google Scholar]
- 17.Koehler KC, Anseth KS, Bowman CN. Biomacromolecules. 2013;14:538–547. doi: 10.1021/bm301789d. [DOI] [PubMed] [Google Scholar]
- 18.Baldwin AD, Kiick KL. Bioconjug Chem. 2011;22:1946–1953. doi: 10.1021/bc200148v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dimitrov DS. Methods Mol Biol. 2012;899:1–26. doi: 10.1007/978-1-61779-921-1_1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jain KK. Applications of Biotechnology in Oncology. 2014 Springer;:617–669. [Google Scholar]
- 21.Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Adv Mater. 2009;21:3307–3329. doi: 10.1002/adma.200802106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hoare TR, Kohane DS. Polymer. 2008;49:1993–2007. [Google Scholar]
- 23.Li Y, Rodrigues J, Tomas H. Chem Soc Rev. 2012;41:2193–2221. doi: 10.1039/c1cs15203c. [DOI] [PubMed] [Google Scholar]
- 24.Vermonden T, Censi R, Hennink WE. Chem Rev. 2012;112:2853–2888. doi: 10.1021/cr200157d. [DOI] [PubMed] [Google Scholar]
- 25.Aimetti AA, Machen AJ, Anseth KS. Biomaterials. 2009;30:6048–6054. doi: 10.1016/j.biomaterials.2009.07.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fu Y, Kao WJ. Expert Opin Drug Deliv. 2010;7:429–444. doi: 10.1517/17425241003602259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Diab T, Pritchard EM, Uhrig BA, Boerckel JD, Kaplan DL, Guldberg RE. J Mech Behav Biomed Mater. 2012;11:123–131. doi: 10.1016/j.jmbbm.2011.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sahoo S, Chung C, Khetan S, Burdick JA. Biomacromolecules. 2008;9:1088–1092. doi: 10.1021/bm800051m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rehmann MS, Garibian AC, Kloxin AM. Macromol Symp. 2013;329:58–65. doi: 10.1002/masy.201200133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Science. 2009;324:59–63. doi: 10.1126/science.1169494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kloxin AM, Tibbitt MW, Kasko AM, Fairbairn JA, Anseth KS. Adv Mater. 2010;22 doi: 10.1002/adma.200900917. 61-+ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Griffin DR, Schlosser JL, Lam SF, Nguyen TH, Maynard HD, Kasko AM. Biomacromolecules. 2013;14:1199–1207. doi: 10.1021/bm400169d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Patterson J, Hubbell JA. Biomaterials. 2010;31:7836–7845. doi: 10.1016/j.biomaterials.2010.06.061. [DOI] [PubMed] [Google Scholar]
- 34.Balendiran GK, Dabur R, Fraser D. Cell Biochem Funct. 2004;22:343–352. doi: 10.1002/cbf.1149. [DOI] [PubMed] [Google Scholar]
- 35.Meng F, Hennink WE, Zhong Z. Biomaterials. 2009;30:2180–2198. doi: 10.1016/j.biomaterials.2009.01.026. [DOI] [PubMed] [Google Scholar]
- 36.Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z. J Control Release. 2011;152:2–12. doi: 10.1016/j.jconrel.2011.01.030. [DOI] [PubMed] [Google Scholar]
- 37.Cai XJ, Dong HQ, Xia WJ, Wen HY, Li XQ, Yu JH, Li YY, Shi DL. J Mater Chem. 2011;21:14639–14645. [Google Scholar]
- 38.Liu J, Pang Y, Huang W, Huang X, Meng L, Zhu X, Zhou Y, Yan D. Biomacromolecules. 2011;12:1567–1577. doi: 10.1021/bm200275j. [DOI] [PubMed] [Google Scholar]
- 39.Wen HY, Dong HQ, Xie WJ, Li YY, Wang K, Pauletti GM, Shi DL. Chem Commun. 2011;47:3550–3552. doi: 10.1039/c0cc04983b. [DOI] [PubMed] [Google Scholar]
- 40.Ferruzzi E, Franceschini R, Cazzolato G, Geroni C, Fowst C, Pastorino U, Tradati N, Tursi J, Dittadi R, Gion M. Eur J Cancer. 2003;39:1019–1029. doi: 10.1016/s0959-8049(03)00122-9. [DOI] [PubMed] [Google Scholar]
- 41.Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Eur Rev Med Pharmacol Sci. 2005;9:361–367. [PubMed] [Google Scholar]
- 42.Estrela JM, Ortega A, Obrador E. Crit Rev Clin Lab Sci. 2006;43:143–181. doi: 10.1080/10408360500523878. [DOI] [PubMed] [Google Scholar]
- 43.Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. J Nutr. 2004;134:489–492. doi: 10.1093/jn/134.3.489. [DOI] [PubMed] [Google Scholar]
- 44.Gajewska J, Szczypka M, Pych K, Borowka A, Laskowska-Klita T. Neoplasma. 1994;42:167–172. [PubMed] [Google Scholar]
- 45.Schultz KM, Baldwin AD, Kiick KL, Furst EM. Macromolecules. 2009;42:5310–5316. doi: 10.1021/ma900766u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Robinson KG, Nie T, Baldwin AD, Yang EC, Kiick KL, Akins RE., Jr J Biomed Mater Res A. 2012;100:1356–1367. doi: 10.1002/jbm.a.34075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lin CC, Anseth KS. Pharm Res. 2009;26:631–643. doi: 10.1007/s11095-008-9801-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Phelps EA, Enemchukwu NO, Fiore VF, Sy JC, Murthy N, Sulchek TA, Barker TH, Garcia AJ. Adv Mater. 2012;24:64–70. doi: 10.1002/adma.201103574. 62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Lei Y, Segura T. Biomaterials. 2009;30:254–265. doi: 10.1016/j.biomaterials.2008.09.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.McGann CL, Levenson EA, Kiick KL. Macromol Chem Phys. 2013;214:203–213. doi: 10.1002/macp.201200412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Gupta D, Tator CH, Shoichet MS. Biomaterials. 2006;27:2370–2379. doi: 10.1016/j.biomaterials.2005.11.015. [DOI] [PubMed] [Google Scholar]
- 52.Nguyen L-TT, Gokmen MT, Du Prez FE. Polym Chem. 2013;4:5527–5536. [Google Scholar]
- 53.Danehy JP, Kn Paramesw. J Chem Eng Data. 1968;13 386-&. [Google Scholar]
- 54.DeCollo TV, Lees WJ. J Org Chem. 2001;66:4244–4249. doi: 10.1021/jo015600a. [DOI] [PubMed] [Google Scholar]
- 55.Treloar LRG. The physics of rubber elasticity. Oxford University Press; 1975. [Google Scholar]
- 56.Gschwend PM, Imboden DM. Environmental organic chemistry. John Wiley & Sons; 2005. [Google Scholar]
- 57.Jo YS, Gantz J, Hubbell JA, Lutolf MP. Soft Matter. 2009;5:440–446. [Google Scholar]
- 58.Martens PJ, Bryant SJ, Anseth KS. Biomacromolecules. 2003;4:283–292. doi: 10.1021/bm025666v. [DOI] [PubMed] [Google Scholar]
- 59.Schoenmakers RG, van de Wetering P, Elbert DL, Hubbell JA. J Control Release. 2004;95:291–300. doi: 10.1016/j.jconrel.2003.12.009. [DOI] [PubMed] [Google Scholar]
- 60.Branco MC, Pochan DJ, Wagner NJ, Schneider JP. Biomaterials. 2010;31:9527–9534. doi: 10.1016/j.biomaterials.2010.08.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Siepmann J, Peppas NA. Adv Drug Deliver Rev. 2012;64:163–174. [Google Scholar]
- 62.Siepmann J, Siepmann F. Int J Pharm. 2008;364:328–343. doi: 10.1016/j.ijpharm.2008.09.004. [DOI] [PubMed] [Google Scholar]
- 63.Zustiak SP, Leach JB. Biotechnol Bioeng. 2011;108:197–206. doi: 10.1002/bit.22911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Raza A, Lin CC. Macromol Biosci. 2013;13:1048–1058. doi: 10.1002/mabi.201300044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Choh SY, Cross D, Wang C. Biomacromolecules. 2011;12:1126–1136. doi: 10.1021/bm101451k. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.